On April 25, 2025, NBC reported that a man went blind after being prescribed Ozempic. But warning signs were already surfacing.
Back on November 21, 2024, I posted a mock scenario connecting GLP-1 medications like Ozempic to NAION (a rare vision condition). The goal? To demonstrate how personal AI agents could surface personally relevant risks long before the science is settled or lawsuits begin.
This is a glimpse of the 3-Zone model outlined in Wealthcare—where AI agents act as digital fiduciaries, protecting individuals in real time by continuously translating emerging data into individualized insight.
We can no longer wait for slow science or blanket guidelines. Should “Ask your doctor” shift to “Ask your Agent” first?
💬 I’d love to hear your thoughts. Could AI have prevented this outcome? Which Web3/AI teams are already building parts of the 3-Zone model?
